Titlebook: New Antimicrobials: For the Present and the Future; I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l

夜晚

Constituent

Confound

制造

FLIC

New Antiviral Agents for Cytomegalovirus Diseases-resistant strains. Two new drugs to combat CMV infections have been recently approved: letermovir tablets and injections for prophylactic treatment of HSCT and maribavir for refractory or drug-resistant CMV infections. Their chemistry, antiviral activity, pharmacokinetics, efficacy, and safety are reviewed in this chapter.

消灭

Direct Antiviral Agents for Hepatitis C now five fixed combinations and eight DAA for treatment of chronic hepatitis C, the choice and duration depending on the genotype, presence or absence of cirrhosis, previous treatment, and renal impairment. The various combinations will be reviewed including mechanisms of action, efficacy, adverse effects, and cost.

贪婪的人

Book 2023tance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO‘s top priorities, but in 2017, it conceded that the current drug development pipel

Irritate

A New Fluoroquinolone: Delafloxacine for intravenous and oral administration and is approved in several countries for skin and soft tissue infections. In this chapter the antimicrobial activity, pharmacokinetic/pharmacodynamics properties, clinical efficacy, and side effects are reviewed.

征兵

施加

1573-4684 re, antimicrobial spectrum, dosage, efficacy, and more for eThis is a timely and essential companion to the recently published .Antimicrobial Resistance in the 21st Century, Second Edition. .Antimicrobial resistance is a major threat to global population health, with government reports projecting it